AstraZeneca plc made a takeover proposal of about $10 billion for Rhythm Pharmaceuticals Inc. reaching up to $134 a share, people familiar with the matter said late Wednesday.
AstraZeneca Makes $10B Offer for Rhythm
AstraZeneca submitted a non-binding proposal of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals. The potential deal would expand AstraZeneca's rare-disease portfolio through its Alexion unit.
Xurve View
Insights:
Xurve View
